ArticleMedical oncology (Northwood, London, England)2018

Significance of introduction of alternative dosing schedule for sunitinib during first-line treatment of patients with metastatic renal cell carcinoma.

Hideaki Miyake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.